197 related articles for article (PubMed ID: 28156209)
1. Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border.
Weber C; Krug O; Kamber M; Thevis M
Subst Use Misuse; 2017 May; 52(6):742-753. PubMed ID: 28156209
[TBL] [Abstract][Full Text] [Related]
2. Identification of black market products and potential doping agents in Germany 2010-2013.
Krug O; Thomas A; Walpurgis K; Piper T; Sigmund G; Schänzer W; Laussmann T; Thevis M
Eur J Clin Pharmacol; 2014 Nov; 70(11):1303-11. PubMed ID: 25168622
[TBL] [Abstract][Full Text] [Related]
3. Seizures of doping substances at the Swiss Border--a descriptive investigation.
Weber C; Kamber M; Lentillon-Kaestner V; Krug O; Thevis M
Forensic Sci Int; 2015 Dec; 257():359-368. PubMed ID: 26517824
[TBL] [Abstract][Full Text] [Related]
4. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P
Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218
[TBL] [Abstract][Full Text] [Related]
5. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
6. Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders.
Fabresse N; Gheddar L; Kintz P; Knapp A; Larabi IA; Alvarez JC
Forensic Sci Int; 2021 May; 322():110771. PubMed ID: 33838562
[TBL] [Abstract][Full Text] [Related]
7. [Not Available].
Bieri A; Kamber M; Sterchi M; Mullis PE
Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
[TBL] [Abstract][Full Text] [Related]
8. An overview on performance and image enhancing drugs (PIEDs) confiscated in Italy in the period 2017-2019.
Odoardi S; Mestria S; Biosa G; Valentini V; Federici S; Strano Rossi S
Clin Toxicol (Phila); 2021 Jan; 59(1):47-52. PubMed ID: 32475176
[TBL] [Abstract][Full Text] [Related]
9. Sports drug testing using complementary matrices: Advantages and limitations.
Thevis M; Geyer H; Tretzel L; Schänzer W
J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial.
Popławska M; Błażewicz A
Drug Test Anal; 2019 Jan; 11(1):162-167. PubMed ID: 30051972
[TBL] [Abstract][Full Text] [Related]
11. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.
Kohler M; Thomas A; Geyer H; Petrou M; Schänzer W; Thevis M
Drug Test Anal; 2010; 2(11-12):533-7. PubMed ID: 21204286
[TBL] [Abstract][Full Text] [Related]
12. The analytical chemistry of drug monitoring in athletes.
Bowers LD
Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
[TBL] [Abstract][Full Text] [Related]
13. Detection of an unknown fusion protein in confiscated black market products.
Walpurgis K; Krug O; Thomas A; Laussmann T; Schänzer W; Thevis M
Drug Test Anal; 2014; 6(11-12):1117-24. PubMed ID: 25219942
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
Thevis M; Schänzer W
Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
[TBL] [Abstract][Full Text] [Related]
15. An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile.
Piper T; Heimbach S; Adamczewski M; Thevis M
Drug Test Anal; 2021 May; 13(5):916-928. PubMed ID: 33283964
[TBL] [Abstract][Full Text] [Related]
16. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
Thevis M; Thomas A; Schänzer W
Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
[TBL] [Abstract][Full Text] [Related]
17. Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.
Thevis M; Geyer H; Thomas A; Schänzer W
Drug Test Anal; 2011 May; 3(5):331-6. PubMed ID: 21538997
[TBL] [Abstract][Full Text] [Related]
18. Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control.
Ahrens BD; Starcevic B; Butch AW
Methods Mol Biol; 2012; 902():115-28. PubMed ID: 22767112
[TBL] [Abstract][Full Text] [Related]
19. Analytical progresses of the World Anti-Doping Agency Olympic laboratories: a 2016 update from London to Rio.
Athanasiadou I; Voss S; Lyris E; Aljaber A; Alsayrafi M; Georgakopoulos C
Bioanalysis; 2016 Nov; 8(21):2265-2279. PubMed ID: 27665839
[TBL] [Abstract][Full Text] [Related]
20. Nutritional supplements cross-contaminated and faked with doping substances.
Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
